Brain-related diseases highly affect the function of other body organs due to their central role in enhancing the coordination of activities. Two common illnesses that negatively influence the quality of living among individuals include Parkinson’s and Huntington’s sickness. Both conditions show different symptoms despite the common variable affecting the state of the human brain. On the one hand, a person suffering from Parkinson’s receives medication, although it is incurable (Fanning et al., 2020). On the other hand, the treatment of Huntington’s encompasses the use of talk therapies that reduce amnesia and delusional moments (Bachoud‐Lévi et al., 2021). The damage to the nerves in the brain causes a significant range of signs among the victims while affecting self-dependence.
The damage to nerve cells disrupts the operations that enhance the transmission of information from the brain to all body parts for a relative response. However, the two diseases pose a different levels of impact on the dysfunction and coordination of the organs. On the one hand, Parkinson’s illness is a disorder within the central nervous system that causes tremors mainly in the victim’s hands (Fanning et al., 2020). On the other hand, Huntington’s sickness encapsulates the inheritance of the condition of the eventual breakdown of the brain’s nerve cells. The dynamic impact on the body from the conditions fosters the differential signs and levels of impairment. An excellent example is the increased rate of hallucinations, compulsive behavior tendencies, mental confusion, and difficulty in understanding and thinking (Bachoud‐Lévi et al., 2021). However, it is distinct from Parkinson’s syndrome encompassing general body tremors, muscle stiffness, amnesia, poor sense of smell, and distortion of jawbones.
Consequently, conditions that proficiently affect the function of the brain foster apparent damage to the nerve cells. As a result, it is important to integrate dynamic treatment strategies to boost the quality of living among the victims. Although both illnesses are genetically inherited, it is crucial that medical practitioners focus on the development of initiatives that reduce harm to the body’s organs. Parkinson’s and Huntington’s disorders require optimal attention due to the negative impact based on the syndromes.
Bachoud‐Lévi, A. C., Massart, R., & Rosser, A. (2021). Cell therapy in Huntington’s disease: Taking stock of past studies to move the field forward. Stem Cells, 39(2), 144-155. Web.
Fanning, S., Selkoe, D., & Dettmer, U. (2020). Parkinson’s disease: Proteinopathy or lipidopathy?. NPJ Parkinson’s Disease, 6(1), 1-9. Web.